NO995302L - Kontrollert frigjoering av medikamenter avlevert ved sublingual eller bukkal administrering - Google Patents

Kontrollert frigjoering av medikamenter avlevert ved sublingual eller bukkal administrering

Info

Publication number
NO995302L
NO995302L NO995302A NO995302A NO995302L NO 995302 L NO995302 L NO 995302L NO 995302 A NO995302 A NO 995302A NO 995302 A NO995302 A NO 995302A NO 995302 L NO995302 L NO 995302L
Authority
NO
Norway
Prior art keywords
sublingual
controlled release
buccal administration
drugs delivered
drugs
Prior art date
Application number
NO995302A
Other languages
English (en)
Other versions
NO995302D0 (no
Inventor
Ragab El-Rashidy
Bruce Ronsen
Emad Eldin Hassan
Original Assignee
Pentech Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pentech Pharmaceuticals Inc filed Critical Pentech Pharmaceuticals Inc
Publication of NO995302D0 publication Critical patent/NO995302D0/no
Publication of NO995302L publication Critical patent/NO995302L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO995302A 1997-04-29 1999-10-29 Kontrollert frigjoering av medikamenter avlevert ved sublingual eller bukkal administrering NO995302L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/841,250 US5888534A (en) 1995-06-13 1997-04-29 Controlled release of drugs delivered by sublingual or buccal administration
PCT/US1998/008630 WO1998048781A1 (en) 1997-04-29 1998-04-29 Controlled release of drugs delivered by sublingual or buccal administration

Publications (2)

Publication Number Publication Date
NO995302D0 NO995302D0 (no) 1999-10-29
NO995302L true NO995302L (no) 1999-12-27

Family

ID=25284405

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995302A NO995302L (no) 1997-04-29 1999-10-29 Kontrollert frigjoering av medikamenter avlevert ved sublingual eller bukkal administrering

Country Status (23)

Country Link
US (1) US5888534A (no)
EP (1) EP1017371B1 (no)
JP (1) JP4948691B2 (no)
CN (1) CN1135103C (no)
AR (1) AR012615A1 (no)
AT (1) ATE244000T1 (no)
BR (1) BR9808703A (no)
CA (1) CA2289260C (no)
CO (1) CO4940397A1 (no)
CZ (1) CZ292513B6 (no)
DE (1) DE69816103T2 (no)
DK (1) DK1017371T3 (no)
ES (1) ES2201487T3 (no)
HK (1) HK1031334A1 (no)
HU (1) HU225108B1 (no)
IL (1) IL132646A0 (no)
NO (1) NO995302L (no)
NZ (1) NZ501114A (no)
PL (1) PL336759A1 (no)
PT (1) PT1017371E (no)
TW (1) TW430562B (no)
WO (1) WO1998048781A1 (no)
ZA (1) ZA983548B (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436950B1 (en) * 1998-08-14 2002-08-20 Nastech Pharmaceutical Company, Inc. Nasal delivery of apomorphine
UA67802C2 (uk) 1998-10-23 2004-07-15 Пфайзер Рісьоч Енд Дівелепмент Компані, Н.В./С.А. Фармацевтична композиція з контрольованим вивільненням інгібітора цгмф фде-5 (варіанти), спосіб її одержання та спосіб лікування еректильної дисфункції
US20030083231A1 (en) * 1998-11-24 2003-05-01 Ahlem Clarence N. Blood cell deficiency treatment method
US6291471B1 (en) 1998-12-17 2001-09-18 Abb Holdings, Inc. Use of apomorphine for the treatment of organic erectile dysfunction in males
FI109453B (fi) 1999-06-30 2002-08-15 Orion Yhtymae Oyj Farmaseuttinen koostumus
CZ20023637A3 (cs) 2000-04-07 2003-02-12 Tap Pharmaceutical Products, Inc. Deriváty apomorfinu a způsoby jejich použití
WO2002039879A2 (en) * 2000-11-15 2002-05-23 Tap Pharmaceutical Products, Inc. Treatment of anti-depression drug-induced sexual dysfunction with apomorphine
IL157320A0 (en) * 2001-02-08 2004-02-19 Pharmacia Corp Rapid-onset medicament for the treatment of sexual dysfunction
US6585997B2 (en) 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
US20060073174A1 (en) * 2001-08-16 2006-04-06 Access Pharmaceuticals, Inc. Adherent and erodible film to treat a moist surface of a body tissue
WO2003032953A1 (fr) * 2001-10-17 2003-04-24 Takeda Chemical Industries, Ltd. Granules contenant un agent chimique instable en milieu acide, en concentration elevee
EP1471890B1 (en) * 2002-02-07 2006-09-27 Pharmacia Corporation Pharmaceutical dosage form for mucosal delivery
AU2003223304A1 (en) * 2002-03-19 2003-10-08 Michael Holick Glycoside and orthoester glycoside derivatives of apomorphine, analogs, and uses thereof
US20040109889A1 (en) * 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
US7306812B2 (en) 2003-05-09 2007-12-11 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device
US7276246B2 (en) * 2003-05-09 2007-10-02 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device
CA2491665A1 (fr) * 2004-12-24 2006-06-24 Louis Cartilier Formulation de comprime pour liberation soutenue de principe actif
AU2006269225B2 (en) * 2005-07-07 2011-10-06 Farnam Companies, Inc. Sustained release pharmaceutical compositions for highly water soluble drugs
US20070020186A1 (en) 2005-07-22 2007-01-25 Alpex Pharma S.A. Solid dosage formulations of narcotic drugs having improved buccal adsorption
JP2009149524A (ja) * 2006-03-16 2009-07-09 Kyushu Univ アルツハイマー病の予防・治療剤
GB2437488A (en) * 2006-04-25 2007-10-31 Optinose As Pharmaceutical oily formulation for nasal or buccal administration
BRPI0822655A2 (pt) 2008-06-04 2015-06-30 Colgate Palmolive Co Implemento e sistema para cuidado oral
US20130213393A1 (en) 2009-12-22 2013-08-22 Evoke Pharma, Inc. Nasal formulations of metoclopramide
CN101475145B (zh) * 2009-01-20 2014-10-22 同济大学 一种具有磁热和靶向药物缓释特性的水滑石及其制备方法
EP2952191B1 (en) * 2009-06-12 2018-08-22 Sunovion Pharmaceuticals Inc. Sublingual apomorphine
CA2772191A1 (en) * 2009-09-04 2011-03-10 Munisekhar Medasani Method of treatment of neurodegenerative or neuro-muscular degenerative diseases and therapeutic agent to treat the same
CN102770152B (zh) 2009-11-25 2016-07-06 阿瑞斯根股份有限公司 肽类的粘膜递送
AU2011343429B2 (en) 2010-12-16 2016-10-20 Sunovion Pharmaceuticals Inc. Sublingual films
DK2706986T3 (en) 2011-09-19 2015-06-01 Orexo Ab NEW ADDICTION PREVENTING PHARMACEUTICAL COMPOSITION FOR TREATMENT OF OPIOID ADDICTION
US20140256822A1 (en) * 2013-03-11 2014-09-11 Pharmaceutical Productions Inc. Transmucosal drug delivery system
JP7211706B2 (ja) 2015-04-21 2023-01-24 サノヴィオン ファーマシュティカルズ インコーポレーテッド 口腔粘膜へのアポモルフィンの投与によるパーキンソン病の治療方法
CA3047088A1 (en) 2016-12-15 2018-06-21 Evoke Pharma, Inc. Treatment of moderate and severe gastroparesis
CN114007617A (zh) * 2019-05-31 2022-02-01 葡瑞慕生物技术有限公司 用于经黏膜给药药物活性成分的单位剂型

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2818855A (en) * 1954-02-11 1958-01-07 Anthony P Miller Surgical device
US3428728A (en) * 1965-10-21 1969-02-18 Hans Lowey Timed release sublingual medications
US4127118B1 (en) * 1977-03-16 1995-12-19 Alvaro Latorre Method of effecting and enhancing an erection
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment
US5256652A (en) * 1987-11-12 1993-10-26 Pharmedic Co. Topical compositions and methods for treatment of male impotence
US5419917A (en) * 1994-02-14 1995-05-30 Andrx Pharmaceuticals, Inc. Controlled release hydrogel formulation
ES2256999T3 (es) * 1994-04-22 2006-07-16 Pentech Pharmaceuticals, Inc. Composcion sublingual que contiene apomorfina para el diagnostico de la impotencia funcional.
US5624677A (en) * 1995-06-13 1997-04-29 Pentech Pharmaceuticals, Inc. Controlled release of drugs delivered by sublingual or buccal administration
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions

Also Published As

Publication number Publication date
HUP0003405A2 (hu) 2001-02-28
CA2289260C (en) 2008-02-12
ZA983548B (en) 1999-01-28
CZ386099A3 (cs) 2000-04-12
WO1998048781A1 (en) 1998-11-05
CN1271276A (zh) 2000-10-25
TW430562B (en) 2001-04-21
ES2201487T3 (es) 2004-03-16
HU225108B1 (en) 2006-06-28
ATE244000T1 (de) 2003-07-15
DE69816103T2 (de) 2004-04-15
CO4940397A1 (es) 2000-07-24
CZ292513B6 (cs) 2003-10-15
EP1017371A1 (en) 2000-07-12
DE69816103D1 (de) 2003-08-07
PL336759A1 (en) 2000-07-17
NO995302D0 (no) 1999-10-29
US5888534A (en) 1999-03-30
PT1017371E (pt) 2003-10-31
CA2289260A1 (en) 1998-11-05
CN1135103C (zh) 2004-01-21
IL132646A0 (en) 2001-03-19
HK1031334A1 (en) 2001-06-15
EP1017371A4 (en) 2000-07-12
EP1017371B1 (en) 2003-07-02
AR012615A1 (es) 2000-11-08
JP2001527546A (ja) 2001-12-25
NZ501114A (en) 2001-09-28
JP4948691B2 (ja) 2012-06-06
BR9808703A (pt) 2001-11-20
HUP0003405A3 (en) 2001-04-28
DK1017371T3 (da) 2003-09-29

Similar Documents

Publication Publication Date Title
NO995302L (no) Kontrollert frigjoering av medikamenter avlevert ved sublingual eller bukkal administrering
DE69738333D1 (de) Nichtpolare Spray zur bukkalen Verabreichung
NO20001195L (no) Bruddheling ved anvendelse av PTHrP-analoger
NO20002851D0 (no) Blandinger for nasal administrasjon av medikamenter
NO995753D0 (no) Gastroretarderende mikrosfaerer med styrt frigivelse for bedret administrasjon av medikament
NO20003150L (no) FremgangsmÕte for fremstilling av tabletter som oppløses ved tygging
IS2184B (is) Lyfjaform með áfangalosun til inntöku um munn
TR199600038A2 (tr) Seker kaplamalardan steroidlerin kontrollü bir sekilde saliverilmesi.
IS4385A (is) Stjórnuð losun stera úr sykruhúðum
EE04901B1 (et) Peroraalne farmatseutiline pikendatud vabanemisega annusvorm
NO995500D0 (no) Anvendelse av en farmasöytisk sammensetning til behandling av/eller forhindring av ischemi
AU1689599A (en) Sustained release medicinal compositions
NO20003161D0 (no) Blandinger for nasal administrasjon av kannabinoider
ZA986889B (en) Controlled release pharmaceutical compositions containing tiagabine
ATE264677T1 (de) Feste arzneizubereitung enthaltend benzofuranderivate
EP1171134A4 (en) CONTROLLED DELIVERY OF SILDENAFIL ADMINISTERED BY SUBLINGUAL OR ORAL
AU3694899A (en) Safety coating of frangible ware
ATE227733T1 (de) Herstellung von avermectin-verbindungen
SI1017371T1 (en) Controlled release of drugs delivered by sublingual or buccal administration
IT242732Y1 (it) Attacco ortodontico
NO982975L (no) FremgangsmÕte for fremstilling av fosfatbundne keramer
NO994140D0 (no) Farmasöytisk sammensetning for den programerte frigivelse av deksfenfluramin
ITCT940014A0 (it) Mattonella di terra cotta bugnata "rossa dell'etna"
ID21130A (id) Struktur pengaman peluncur
FI955053A0 (fi) Anordning foer nedbylning eller uppvaermning av vaetska med gasformigt medel

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application